Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
106 studies found for:    Open Studies | "Pulmonary Fibrosis"
Show Display Options
Rank Status Study
21 Recruiting Investigating Idiopathic Pulmonary Fibrosis in Greece (INDULGE IPF)
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
22 Recruiting Early Diagnosis of Pulmonary Fibrosis - Use of Biomarkers in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
23 Recruiting Integrating Palliative Care for Patients With Idiopathic Pulmonary Fibrosis and Their Caregivers
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Other: SUPPORT;   Other: Currently Available Printed Material
24 Not yet recruiting Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: GSK3008348;   Drug: Placebo;   Drug: [18F]-FBA-A20FMDV2
25 Recruiting Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Behavioral: Physical exercise training;   Behavioral: Cognitive exercise training
26 Recruiting Lung MRI in the Management of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Device: MRI;   Other: Thoracic HRCT (standard reference)
27 Not yet recruiting A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Valganciclovir;   Drug: Placebo
28 Recruiting 68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary Fibrosis
Condition: Pulmonary Fibrosis, Unspecified
Interventions: Drug: 68Ga-NOTA-PRGD2;   Device: PET/CT
29 Recruiting Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Cyclophosphamide;   Drug: Placebo;   Drug: Corticosteroid (prednisolone)
30 Recruiting PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
31 Recruiting Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
32 Recruiting Health-related Quality of Life and Comorbidities in Danish Patients With Idiopathic Pulmonary Fibrosis - a Nationwide Follow-up
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
33 Not yet recruiting Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Other: patientMpower platform;   Other: usual care
34 Recruiting Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: nintedanib;   Drug: placebo
35 Recruiting Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
36 Recruiting Efficacy and Safety of Nintedanib When Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Nintedanib;   Drug: Placebo;   Drug: Sildenafil
37 Recruiting Nebulized Fentanyl in Patients With Mild to Moderate Idiopathic Pulmonary Fibrosis and Chronic Dyspnea
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Fentanyl Citrate;   Drug: Placebo
38 Recruiting Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial
Condition: Idiopathic Pulmonary Fibrosis (IPF)
Intervention: Drug: Dasatinib + Quercetin
39 Recruiting Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis (IPF)
Intervention:
40 Recruiting Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Pirfenidone;   Drug: Placebo;   Drug: Sildenafil

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.